Regan Rostorfer

Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer

Sara A. Hurvitz, Miguel Martín, Michael F. Press et al. · Clinical Cancer Research · 2019 · 220 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract PD5-01: Final results of NeoMONARCH: A phase 2 neoadjuvant study of abemaciclib in postmenopausal women with hormone receptor positive (HR+), HER2 negative breast cancer (BC)

Miguel Martín, SA Hurvitz, Ding‐Cheng Chan et al. · Cancer Research · 2018 · 24 citations

Medicine, Oncology, Pharmacology +17

breast cancer, early stage Interim results from neoMONARCH: A neoadjuvant phase II study of abemaciclib in postmenopausal women with HR + /HER2- breast cancer (BC)

Sara A. Hurvitz, María Fernández Abad, Regan Rostorfer et al. · Annals of Oncology · 2016 · 19 citations

Medicine, Oncology, Pharmacology +17

Abstract S4-06: Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cancer

Sara A. Hurvitz, Miguel Martín, María Fernández Abad et al. · Cancer Research · 2017 · 15 citations

Medicine, Oncology, Pharmacology +17